Stratec Se Stock

Stratec Se EBIT

The EBIT of Stratec Se (SBS.DE) as of Aug 17, 2026 is 8.59 M EUR. In the previous year, EBIT was 28.18 M EUR — a change of -69.51% (lower).

EBIT

8.59 MEUR

YoY

-69.51%

Last updated:

In 2026, Stratec Se's EBIT was 8.59 M EUR, a -69.51% increase from the 28.18 M EUR EBIT recorded in the previous year.

The Stratec Se EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M EUR)
Date
EBIT (M EUR)
Jan 1, 2024
28.18 base
Jan 1, 2025
8.59 base
Jan 1, 2026 (e)
29.14 base
Jan 1, 2027 (e)
31.08 base
Jan 1, 2028 (e)
33.09 base
Jan 1, 2029 (e)
36.11 base
Jan 1, 2030 (e)
38.81 base
Jan 1, 2031 (e)
0.00 base
YEAREBIT (M EUR)
2031 est -
2030 est 38.81
2029 est 36.11
2028 est 33.09
2027 est 31.08
2026 est 29.14
2025 8.59
2024 28.18
2023 28.12
2022 42.00
2021 49.63
2020 33.51
2019 18.21
2018 15.38
2017 30.51
2016 24.20
2015 26.88
2014 24.05
2013 19.49
2012 15.58
2011 21.84
2010 17.61
2009 14.38
2008 4.55
2007 31.45
2006 38.34
Access this data via the Eulerpool API

Stratec Se Revenue

Stratec Se Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
257.62 M EUR
28.18 M EUR
16.02 M EUR
Jan 1, 2025
250.86 M EUR
8.59 M EUR
-242,000.00 EUR
Jan 1, 2026 (e)
263.66 M EUR
29.14 M EUR
16.95 M EUR
Jan 1, 2027 (e)
281.26 M EUR
31.08 M EUR
20.66 M EUR
Jan 1, 2028 (e)
299.41 M EUR
33.09 M EUR
24.39 M EUR
Jan 1, 2029 (e)
326.71 M EUR
36.11 M EUR
27.53 M EUR
Jan 1, 2030 (e)
351.17 M EUR
38.81 M EUR
31.49 M EUR
Jan 1, 2031 (e)
363.75 M EUR
0.00 EUR
0.00 EUR

Stratec Se Margins

Stratec Se stock margins

The Stratec Se margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Stratec Se. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Stratec Se.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
29.65 %
10.94 %
6.22 %
Jan 1, 2025
25.60 %
3.43 %
-0.10 %
Jan 1, 2026 (e)
25.60 %
11.05 %
6.43 %
Jan 1, 2027 (e)
25.60 %
11.05 %
7.34 %
Jan 1, 2028 (e)
25.60 %
11.05 %
8.14 %
Jan 1, 2029 (e)
25.60 %
11.05 %
8.43 %
Jan 1, 2030 (e)
25.60 %
11.05 %
8.97 %
Jan 1, 2031 (e)
25.60 %
0.00 %
0.00 %

Stratec Se Stock analysis

What does Stratec Se do? The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Stratec Se's EBIT

Stratec Se's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Stratec Se's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Stratec Se's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Stratec Se’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Stratec Se stock

EBIT of Stratec Se is 8.59 M EUR in 2026.

EBIT of Stratec Se changed from 28.18 M EUR to 8.59 M EUR, representing a -69.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Stratec Se since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Stratec Se historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Stratec Se

All Key Metrics — Stratec Se